Search results for "publique"

showing 10 items of 601 documents

L'ouverture de fonds d'archives de la Seconde Guerre mondiale

2016

International audience

CULTURESeconde Guerre mondiale[SHS.DROIT]Humanities and Social Sciences/Law[SHS.DROIT] Humanities and Social Sciences/LawArchivesComputingMilieux_MISCELLANEOUSAccès aux archives publiques
researchProduct

Analyse économique des essais cliniques internationaux en cancérologie

2018

International audience; In oncology, as in other fields of medicine, international multicentre clinical trials came into being so as to include a sufficient number of subjects to investigate a clinical situation. The existence of tight budgetary constraints and the desire to make the best use of the resources available have resulted in the development of economic evaluations associated with these trials, which, thanks to their level of evidence and their size, provide particularly relevant material. Nonetheless, economic evaluations alongside international clinical trials raise specific questions of methodology with regard to both the design and the analysis of the results. Indeed, the cost…

Cancer ResearchMéthodologie[SDV.CAN]Life Sciences [q-bio]/Cancer[ SDV.CAN ] Life Sciences [q-bio]/Cancer03 medical and health sciencesEssai clinique international0302 clinical medicineGoods and services[SDV.CAN] Life Sciences [q-bio]/CancerMonetary valueInternational clinical trialMethodsRadiology Nuclear Medicine and imaging030212 general & internal medicineBudget constraintComputingMilieux_MISCELLANEOUSIndividual countryÉvaluation économique.Public economics030503 health policy & services[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologieHematologyGeneral MedicineEvidence-based medicineEconomic evaluation3. Good healthClinical trialEconomic dataOncologyWork (electrical)[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieBusiness0305 other medical science
researchProduct

Expertise préalable à la création d’un tableau de maladie professionnelle ou à l’élaboration de recommandations aux comités régionaux de reconnaissan…

2022

L’amiante est classé en tant que substance cancérogène avérée pour l’humain (groupe 1 du Centre International de Recherche sur la Cancer (CIRC)) depuis les années 70 pour le poumon et la plèvre. La monographie sur l’amiante actualisée en 2012 indique que des preuves suffisantes sont maintenant disponibles pour démontrer le lien entre l’exposition à l’amiante et les cancers du larynx et de l'ovaire. Dans cette monographie, les cancers du pharynx, de l’estomac et les cancers colorectaux sont considérés comme possiblement liés à une exposition à l’amiante, mais avec un niveau de preuve limité.A ce jour, seuls les cancers broncho-pulmonaires provoqués par l'inhalation de poussières d'amiante [t…

Cancer du larynxOvary cancerCancer de l’ovaireMedical diagnosisOccupational diseaseCausal relationshipAsbestosExposition professionnelleOccupational exposureMaladie professionnelleAmianteDiagnostic médical[SDV] Life Sciences [q-bio]Laryngeal cancer[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieCompensationRelation causaleReconnaissance
researchProduct

Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23

2021

Abstract Aims  Our objective was to better understand the genetic bases of dilated cardiomyopathy (DCM), a leading cause of systolic heart failure. Methods and results  We conducted the largest genome-wide association study performed so far in DCM, with 2719 cases and 4440 controls in the discovery population. We identified and replicated two new DCM-associated loci on chromosome 3p25.1 [lead single-nucleotide polymorphism (SNP) rs62232870, P = 8.7 × 10−11 and 7.7 × 10−4 in the discovery and replication steps, respectively] and chromosome 22q11.23 (lead SNP rs7284877, P = 3.3 × 10−8 and 1.4 × 10−3 in the discovery and replication steps, respectively), while confirming two previously identif…

Cardiac & Cardiovascular SystemsCardiomyopathy Dilated/genetics[SDV]Life Sciences [q-bio]Signal Transducing/geneticsDilated cardiomyopathyGenome-wide association studyAdaptor Proteins Signal Transducing/genetics030204 cardiovascular system & hematologyTAURINE0302 clinical medicineGWASMedicinePOSITION STATEMENT1102 Cardiorespiratory Medicine and HaematologyGenetics0303 health scienceseducation.field_of_studyGenetic Predisposition to Disease/geneticsAdaptor ProteinsDilated cardiomyopathy4C-sequencingPolymorphism Single Nucleotide/geneticsGenetic risk scoreCardiology and Cardiovascular MedicineLife Sciences & BiomedicineSingle Nucleotide/geneticsCardiomyopathy DilatedCardiomyopathyPopulationLocus (genetics)Single-nucleotide polymorphismPolymorphism Single NucleotideChromosomes03 medical and health sciencesSystolic/geneticsHeart Failure Systolic/geneticsSNPAnimalsHumansGenetic Predisposition to DiseaseAllelePolymorphismeducationImputationAdaptor Proteins Signal Transducing030304 developmental biologyHeart FailureScience & Technologybusiness.industryWORKING GROUP1103 Clinical Sciencesmedicine.diseaseGenetic architectureCardiovascular System & Hematology Dilated cardiomyopathyDilated/geneticsCardiovascular System & Cardiology[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusinessApoptosis Regulatory ProteinsHeart Failure SystolicGenome-Wide Association Study
researchProduct

Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy

2019

AbstractThe most common causes of ischaemic stroke are represented by carotid artery atherosclerotic disease (CAAD) and atrial fibrillation. While oral anticoagulants substantially reduce the incidence of thromboembolic stroke (< 1%/year), the rate of ischaemic stroke and other cardiovascular disease events in patients with CAAD remains high, ranging from 8.4 to 18.1 events per 100 patient-years. Similar to any other atherosclerotic disease, anti-thrombotic therapies are proposed for CAAD to reduce stroke and other cardiovascular events. The 2017 European Society of Cardiology (ESC)/European Society for Vascular Surgery (ESVS) guidelines recommend for patients with asymptomatic CAAD ≥60%…

Carotid Artery DiseasesMaleRisk0301 basic medicinemedicine.medical_specialtyCardiologyHemorrhageThromboembolic stroke030204 cardiovascular system & hematologyAsymptomatic03 medical and health sciences0302 clinical medicineRivaroxabanCarotid artery diseaseInternal medicineIschaemic strokeMyocardial RevascularizationmedicineHumansAgedAspirinbusiness.industryIncidence (epidemiology)Atherosclerotic diseaseAnticoagulantsAtrial fibrillationHematologyMiddle AgedAtherosclerosismedicine.diseaseClopidogrelReview articleCarotid Arteries030104 developmental biology[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieCardiovascular Diseasesanti-platelet; anti-thrombotic therapy; anticoagulant; aspirin; carotid artery disease; rivaroxabanCardiologyFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiemedicine.symptombusinessPlatelet Aggregation InhibitorsThrombosis and Haemostasis
researchProduct

Non-coronary atherosclerosis

2014

International audience; During the last decades, the clinical and research interest in atherosclerosis has been mostly focused on coronary arteries. After the publications of the European Society Guidelines and AHA/ACC Guidelines on Peripheral artery diseases, and of the Registry REduction in Atherothrombosis for Continued Health Registry, there has been an increased interest in atherosclerosis of the lower extremity arteries and its presence in multifocal disease. However, awareness in the general population and the medical community of non-coronary artery diseases, and of its major prognostic implications remain relatively low. The aim of this general review stemming out of an ESC Working…

Carotid Artery Diseasesmedicine.medical_specialtyPopulationAortic DiseasesComplex diseaseAorta Thoracic610 Medicine & healthDisease2705 Cardiology and Cardiovascular MedicinePeripheral artery circulationUpper ExtremityRenal ArteryMultifocal diseasemedicineHumansAorta AbdominalPeripheral Artery DiseaseseducationIntensive care medicineCoronary atherosclerosisPeripheral Vascular Diseaseseducation.field_of_studybusiness.industry10031 Clinic for AngiologySettore MED/11 - Malattie Dell'Apparato CardiovascolareMesenteric Arteries3. Good healthCoronary arteriesEarly Diagnosismedicine.anatomical_structureLower ExtremityAtherosclerosiPhysical therapy[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieperipheral artery circulation; atherosclerosisArtery diseasesatherosclerosisCardiology and Cardiovascular Medicinebusiness
researchProduct

Molecular evidence for the inverse comorbidity between central nervous system disorders and cancers detected by transcriptomic meta-analyses.

2014

There is epidemiological evidence that patients with certain Central Nervous System (CNS) disorders have a lower than expected probability of developing some types of Cancer. We tested here the hypothesis that this inverse comorbidity is driven by molecular processes common to CNS disorders and Cancers, and that are deregulated in opposite directions. We conducted transcriptomic meta-analyses of three CNS disorders (Alzheimer's disease, Parkinson's disease and Schizophrenia) and three Cancer types (Lung, Prostate, Colorectal) previously described with inverse comorbidities. A significant overlap was observed between the genes upregulated in CNS disorders and downregulated in Cancers, as wel…

Central Nervous SystemCancer ResearchGene ExpressionDiseaseComorbidityBioinformaticsProstate cancer0302 clinical medicineNeoplasmsGenetics (clinical)0303 health sciencesWnt signaling pathwayParkinson DiseaseAlzheimer's diseasePeptidylprolyl Isomerase[SDV.BIBS]Life Sciences [q-bio]/Quantitative Methods [q-bio.QM]3. Good health[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Alzheimer's diseaseResearch ArticleSignal Transductionlcsh:QH426-470[SDV.CAN]Life Sciences [q-bio]/CancerProtein degradationBiology03 medical and health sciencesAlzheimer Disease[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry Molecular Biology/Genomics [q-bio.GN]medicineGeneticsCancer GeneticsHumansGene NetworksMolecular BiologyBiologyEcology Evolution Behavior and Systematics030304 developmental biologyPeptidylprolyl isomeraseGene Expression ProfilingCancerComputational Biologymedicine.diseaseColorectal cancerComorbidityMalariaNIMA-Interacting Peptidylprolyl IsomeraseMeta-analysislcsh:GeneticsGene Expression RegulationImmunologySchizophrenia[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie030217 neurology & neurosurgery
researchProduct

Is loneliness associated with mild cognitive impairment in low- and middle-income countries?

2021

Background: Loneliness may be a risk factor for mild cognitive impairment but studies on this topic are scarce, particularly from low- and middle-income countries (LMICs). Therefore, the aim of the present study was to investigate the association between loneliness and mild cognitive impairment (MCI) in six LMICs (China, Ghana, India, Mexico, Russia and South Africa). Methods: Cross-sectional, community-based, nationally representative data from the WHO Study on global AGEing and adult health (SAGE) were analyzed. The definition of MCI was based on the National Institute on Ageing-Alzheimer's Association criteria. Multivariable logistic regression analysis and meta-analysis were conducted t…

ChinaLogistic regression*multi-countryOdds*loneliness03 medical and health sciences0302 clinical medicinemild cognitive impairmentMESH: Aged; China/epidemiology; Cognitive Dysfunction/epidemiology; Cross-Sectional Studies; Developing Countries; Humans; Loneliness; Middle Aged; PrevalencemedicinePrevalencelonelinessDementiaHumansCognitive Dysfunctionlow- and middle-income countriesRisk factorCognitive impairmentDeveloping CountriesAgedmulti-country030214 geriatricsbusiness.industryLonelinessMiddle Agedmedicine.disease*low- and middle-income countriesConfidence interval3. Good healthPsychiatry and Mental healthCross-Sectional Studies*mild cognitive impairmentLow and middle income countriesloneliness low- and middle-income countries mild cognitive impairment multi-country[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieGeriatrics and Gerontologymedicine.symptombusinessDemography
researchProduct

Human behaviour, benign or malevolent: understanding the human psyche, performing therapy, based on affective mentalization and Matte-Blanco’s bi-log…

2016

International audience; The key concept of Ignacio Matte Blanco’s bi-logic is the unavoidable but variable presence of primary process (symmetric thought) in the secondary one (asymmetric thought) ruling consciousness, for every human being. This variable and dynamic presence allows us, by therapeutic intervention, to convert suitably the symmetric thought into the asymmetric one. The former erupts into the latter by means of affectivity which, accordingly, should be suitably treated to be rightly modulated, regulated and symbolically represented to accomplish the aims of secondary process. This transition has been termed affective mentalization by Peter Fonagy et al. Accordingly, any thera…

Cognitive science[SHS.SOCIO]Humanities and Social Sciences/Sociologybusiness.industryTransition (fiction)media_common.quotation_subjectsocial healthcare[SHS.PSY]Humanities and Social Sciences/PsychologyGeneral Medicinehuman psycheaffective mentalizationHuman beingPsycheEditorialMentalizationIntervention (counseling)Mentalization-based treatmentMedicine[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieConsciousnesscriminologybusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyMatte-Blanco bilogicmedia_commonAnnals of Translational Medicine
researchProduct

Territoire et énergie : politiques locales, échelles d'intervention et instruments de mobilisation, de connaissance et d'action

2011

The thesis is about French local authorities' energy policies, and more particularly about regional policies. In a context of reassessment of fossil fuel-based energy systems, local authorities have a key role to play. Indeed, energy systems are complex and require to act locally, in order to keep fair access for consumers and to adapt supply to needs and uses. In the same way, environmental constraints and sustainable exploitation of local resources involve to have a good knowledge of territory and of local energy potential. But, local authorities do not know much about boundaries and about components of territorial energy systems. The main purpose of the thesis is to determine structure a…

Collectivités territoriales[SHS.GEO] Humanities and Social Sciences/GeographyMobilisation des acteursLocal authoritiesTarritory knowledge[SHS.GEO]Humanities and Social Sciences/GeographyActors’ mobilization[ SHS.GEO ] Humanities and Social Sciences/GeographyApproche territorialePolitique énergétiqueTerritorial approachConnaissance du territoirePolicy instrumentEnergy policyLocal actorsActeurs locauxInstruments de politique publique
researchProduct